| 68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli? T Lengana, IO Lawal, TG Boshomane, GO Popoola, KMG Mokoala, ... Clinical genitourinary cancer 16 (5), 392-401, 2018 | 115 | 2018 |
| 68Ga-FAPI-PET/CT in patients with various gynecological malignancies K Dendl, SA Koerber, R Finck, KMG Mokoala, F Staudinger, L Schillings, ... European journal of nuclear medicine and molecular imaging 48 (12), 4089-4100, 2021 | 107 | 2021 |
| Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617 MM Sathekge, F Bruchertseifer, IO Lawal, M Vorster, O Knoesen, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1756-1757, 2019 | 40 | 2019 |
| mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting: response to treatment and survival analysis M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 63 (10), 1496-1502, 2022 | 38 | 2022 |
| Hematologic toxicity profile and efficacy of [225Ac] Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer IO Lawal, A Morgenstern, M Vorster, O Knoesen, J Mahapane, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (10), 3581-3592, 2022 | 26 | 2022 |
| PSMA theranostics: science and practice K Mokoala, I Lawal, T Lengana, M Kgatle, FL Giesel, M Vorster, ... Cancers 13 (15), 3904, 2021 | 26 | 2021 |
| A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for … IO Lawal, KMG Mokoala, J Mahapane, J Kleyhans, M Meckel, M Vorster, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 134-142, 2021 | 26 | 2021 |
| 225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, K Mokoala, J Reed, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (7), 2210-2218, 2023 | 21 | 2023 |
| Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study MM Sathekge, IO Lawal, C Bal, F Bruchertseifer, S Ballal, G Cardaci, ... The Lancet Oncology 25 (2), 175-183, 2024 | 20 | 2024 |
| Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2 IO Lawal, MM Kgatle, K Mokoala, A Farate, MM Sathekge BMC Cardiovascular Disorders 22 (1), 93, 2022 | 19 | 2022 |
| Immune checkpoints, inhibitors and radionuclides in prostate cancer: Promising combinatorial therapy approach MM Kgatle, TMG Boshomane, IO Lawal, KMG Mokoala, NP Mokgoro, ... International Journal of Molecular Sciences 22 (8), 4109, 2021 | 19 | 2021 |
| Prognostic value of pre-treatment F-18 FDG PET metabolic metrics in patients with locally advanced carcinoma of the anus with and without HIV infection IO Lawal, AO Ankrah, KMG Mokoala, GO Popoola, CA Kaoma, A Maes, ... Nuklearmedizin-NuclearMedicine 57 (05), 190-197, 2018 | 13 | 2018 |
| Impact of optimized PET imaging conditions on 18F-FDG uptake quantification in patients with apparently normal aortas IO Lawal, KG Mokoala, GO Popoola, T Lengana, AO Ankrah, AC Stoltz, ... Journal of Nuclear Cardiology 28 (4), 1349-1359, 2021 | 10 | 2021 |
| [68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG … IO Lawal, GO Popoola, J Mahapane, J Kaufmann, C Davis, H Ndlovu, ... Biomolecules 10 (12), 1629, 2020 | 10 | 2020 |
| Pattern of Prostate Cancer Recurrence Assessed by 68Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy IO Lawal, T Lengana, GO Popoola, AT Orunmuyi, MM Kgatle, ... Journal of Clinical Medicine 10 (17), 3883, 2021 | 9 | 2021 |
| The association of tumor burden by 18F-FDG PET/CT and survival in vulvar carcinoma KMG Mokoala, IO Lawal, T Lengana, GO Popoola, TMG Boshomane, ... Clinical Nuclear Medicine 46 (5), 375-381, 2021 | 8 | 2021 |
| The Use of 18F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma KN Hlongwa, KMG Mokoala, Z Matsena-Zingoni, M Vorster, MM Sathekge Diagnostics 12 (3), 595, 2022 | 7 | 2022 |
| A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F … KMG Mokoala, IO Lawal, LC Maserumule, KN Hlongwa, H Ndlovu, ... Journal of Clinical Medicine 11 (4), 962, 2022 | 7 | 2022 |
| Radionuclide imaging of invasive fungal disease in immunocompromised hosts IO Lawal, KMG Mokoala, MM Kgatle, RAJO Dierckx, AWJM Glaudemans, ... Diagnostics 11 (11), 2057, 2021 | 7 | 2021 |
| Exceptional initial response of prostate cancer lung metastases to 225Ac-PSMA: A case report LC Maserumule, KMG Mokoala, KN Hlongwa, H Ndlovu, JD Reed, ... Current Problems in Cancer: Case Reports 3, 100038, 2021 | 7 | 2021 |
